LIFESTANCE HEALTH GROUP INC
LFSTNASDAQTrading Snapshot
- Day Range
- $11.77 – $12.05
- 52-Week Range
- $4.77 – $13.56
- Volume
- $2.16B
- Avg Volume
- $1.49B
- Shares Outstanding
- 387.8M
- Next Earnings
- Dec 12, 2026
Fundamentals Snapshot
- Annual Revenue
- $1.42B
- Last Q Revenue
- $435M
- P/E Ratio
- 91.0
- P/S Ratio
- 2.9x
- EPS (TTM)
- $0.13
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +3.5%
Why Investors Own LFST
- ✓High-growth profile — revenue up -6.3% YoY with expanding US Equity exposure.
- ✓Healthy economics — 46% gross margin and 11% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
LIFESTANCE HEALTH GROUP INC
LFST
StockOtter · stockotter.spaceAbout LIFESTANCE HEALTH GROUP INC
LifeStance Health Group, Inc. specializes in delivering outpatient mental healthcare services through its subsidiary network. The company offers a comprehensive array of mental health solutions, encompassing psychiatric evaluations and treatment, specialized psychological and neuropsychological testing, and diverse therapeutic modalities including individual, family, and group therapy sessions. The organization addresses a wide spectrum of mental health conditions, ranging from common issues like anxiety and depression to more complex challenges such as bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. Patients have access to care through various channels: virtually via its online platform or in-person at its many centers located throughout 32 states. LifeStance is dedicated to supporting individuals across all age groups, providing care for children, adolescents, adults, and the elderly. LifeStance Health Group, Inc. was founded in 2017 and its main offices are situated in Scottsdale, Arizona.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Analyst Price Target
ⓘLatest News & Updates
LifeStance Health CTO Sells 42,067 Shares for $541,402
Vukasin Paunovich disposed of 42,067 shares. The transaction involved shares equal to 17% of the total stake held by the executive prior to the filing.
74,169 Shares in LifeStance Health Group, Inc. $LFST Bought by HighTower Advisors LLC
HighTower Advisors LLC acquired a new position in LifeStance Health Group, Inc. (NASDAQ: LFST) during the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Co
LifeStance Health Group, Inc. (LFST) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
LifeStance Health Group, Inc. (LFST) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Analyzing Mangoceuticals (NASDAQ:MGRX) and LifeStance Health Group (NASDAQ:LFST)
LifeStance Health Group (NASDAQ: LFST - Get Free Report) and Mangoceuticals (NASDAQ: MGRX - Get Free Report) are both healthcare companies, but which is the better investment? We will compare the two businesses based on
Here's Why LifeStance Health Group (LFST) is a Great Momentum Stock to Buy
Does LifeStance Health Group (LFST) have what it takes to be a top stock pick for momentum investors? Let's find out.
5 Low-Leverage Stocks to Buy Amid Rising Oil Prices & Inflation Woes
Rising oil prices and inflation worries shift the spotlight to five low-leverage stocks, with strong earnings growth & balance sheets.